Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PDL BIOPHARMA INC Key Ratios

  • Valuation Ratio: PDLI

    P/E (TTM) 15.07
    Price to CashFlow 7.27
    Price to Sales (TTM) 3.53
    Price to Book -3.88
  • Per Share Ratio: PDLI

    Dividend Per Share (TTM) 1.00
    Book Value Per Share 1.09
    EPS Fully Diluted 0.41
    Revenue Per Share 1.75
  • 5 Year Annual Growth: PDLI

    Net Income
    Revenue 34.57%
    Dividend Per Share (TTM) 0.00%
    EPS
  • Dividends: PDLI

    Dividend Yield 12.66%
    Dividend Yield - 5 Yr. Avg. 0.00%
    Dividend Per Share (TTM) 1.00
    Dividend Payout Ratio 86.21
  • Profit Margins: PDLI

    Operations Margin 82.55%
    Net Profit Margin 23.24%
    Gross Profit Margin 92.36%
  • Financial Strength: PDLI

    Quick Ratio (MRQ) 5.11
    Current Ratio (MRQ) 0.94
    LT Debt to Equity (MRQ) -94.06
    Total Debt to Equity (MRQ) -176.57
    Return on Equity (ROE) Per Share 18.34
    Return on Assets (ROA) 43.24
    Return on Invested Capital (ROIC) 13.04
  • Assets: PDLI

    Asset Turnover 1.57
    Inventory Turnover 26.34